We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$5.85B
AUM Growth
-$145M
Cap. Flow
-$400M
Cap. Flow %
-6.83%
Top 10 Hldgs %
13.17%
Holding
280
New
19
Increased
117
Reduced
131
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 16.99%
2 Industrials 15.29%
3 Financials 13.49%
4 Healthcare 12.83%
5 Consumer Discretionary 12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHUY
201
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$5.28M 0.09%
188,058
+55,990
+42% +$1.32M
DY icon
202
Dycom Industries
DY
$12.2B
$5.19M 0.09%
46,539
+13,700
+42% +$1.32M
KNX icon
203
Knight Transportation
KNX
$11.2B
$4.81M 0.08%
110,042
+32,397
+42% +$1.33M
SHYF
204
DELISTED
The Shyft Group
SHYF
$4.74M 0.08%
+300,621
New +$4.57M
PTLA
205
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$4.45M 0.08%
+91,402
New +$4.62M
CUB
206
DELISTED
Cubic Corporation
CUB
$4.37M 0.07%
74,170
+21,586
+41% +$1.22M
MMS icon
207
Maximus
MMS
$2.92B
$4.35M 0.07%
60,739
+17,661
+41% +$1.19M
FOLD
208
DELISTED
Amicus Therapeutics
FOLD
$4.28M 0.07%
297,349
+22,289
+8% +$306K
EPAY
209
DELISTED
Bottomline Technologies Inc
EPAY
$4.12M 0.07%
118,836
+34,633
+41% +$1.16M
BRKR icon
210
Bruker
BRKR
$8.61B
$4.05M 0.07%
118,164
+34,953
+42% +$1.14M
TVTX icon
211
Travere Therapeutics
TVTX
$5.77B
$4.01M 0.07%
190,545
+55,130
+41% +$1.26M
MIME
212
DELISTED
Mimecast Limited
MIME
$3.6M 0.06%
125,404
+36,536
+41% +$1.09M
DBVT
213
DBV Technologies
DBVT
$897M
$3.4M 0.06%
13,839
+3,872
+39% +$1.12M
CSII
214
DELISTED
Cardiovascular Systems, Inc.
CSII
$3.22M 0.06%
135,898
+40,133
+42% +$1.01M
HRTG icon
215
Heritage Insurance Holdings
HRTG
$989M
$2.84M 0.05%
157,448
+45,367
+40% +$753K
THR
216
DELISTED
Thermon Group Holdings
THR
$2.46M 0.04%
103,825
+30,473
+42% +$665K
KMB icon
217
Kimberly-Clark
KMB
$36B
$1.4M 0.02%
11,613
+649
+6% +$75.7K
ICLR icon
218
Icon
ICLR
$12.9B
$1.29M 0.02%
11,496
+700
+6% +$80.7K
GHL
219
DELISTED
Greenhill & Co., Inc.
GHL
$1.22M 0.02%
62,592
+17,722
+39% +$330K
ELGX
220
DELISTED
Endologix Inc
ELGX
$1.17M 0.02%
21,811
+6,025
+38% +$318K
KHC icon
221
Kraft Heinz
KHC
$29.4B
$949K 0.02%
12,200
+704
+6% +$55.3K
XOM icon
222
ExxonMobil
XOM
$662B
$654K 0.01%
7,825
-7,878
-50% -$652K
BUD icon
223
AB InBev
BUD
$164B
$638K 0.01%
+5,718
New +$673K
PIPR icon
224
Piper Sandler
PIPR
$5.29B
$524K 0.01%
24,300
+2,740
+13% +$49.4K
PEP icon
225
PepsiCo
PEP
$188B
$499K 0.01%
4,163
-50,126
-92% -$5.72M

Similar funds

GW&K Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, GW&K Investment Management held 280 positions worth $5.85B, down 2.4% from $6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

GW&K Investment Management withdrew a net $400M in Q4 2017, closing 11 positions and reducing 131 holdings. Its most notable exit was Syneos Health, Inc. Class A Common Stock, an estimated $43.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

Against the trend, GW&K Investment Management opened a new position in Amgen worth $35.2M.

  • GW&K Investment Management's largest Q4 2017 buy was Amgen: 202,307 shares worth $35.2M.
  • GW&K Investment Management added most to Impax Laboratories, Inc. in Q4 2017, an estimated $20.3M increase.
  • GW&K Investment Management's biggest Q4 2017 reduction was Sun Communities, cutting an estimated $33.2M.
  • GW&K Investment Management fully exited Syneos Health, Inc. Class A Common Stock in Q4 2017, selling an estimated $43.9M.
  • GW&K Investment Management's ten largest holdings make up 13% of its $5.85B portfolio in Q4 2017.
  • GW&K Investment Management opened 19 new positions and closed 11 in Q4 2017.
  • GW&K Investment Management's portfolio value fell 2.4% quarter-over-quarter to $5.85B.

Based on GW&K Investment Management's 13F filing for Q4 2017, filed 19 Jan 2018.